» Articles » PMID: 10207129

Eph Receptors and Ephrins: Effectors of Morphogenesis

Overview
Journal Development
Specialty Biology
Date 1999 Apr 20
PMID 10207129
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Eph receptor tyrosine kinases and their ligands, the ephrins, appear to lie functionally at the interface between pattern formation and morphogenesis. We review the role of Eph and ephrin signalling in the formation of segmented structures, in the control of axon guidance and cell migration and in the development of the vasculature. We address the question of how the specificity of response is achieved and discuss the specificity of ephrin-Eph interactions and the significance of structural domains in Eph receptors.

Citing Articles

EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities.

Toracchio L, Carrabotta M, Mancarella C, Morrione A, Scotlandi K Int J Mol Sci. 2024; 25(22).

PMID: 39596256 PMC: 11594831. DOI: 10.3390/ijms252212191.


Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response.

Xu S, Zheng Y, Ye M, Shen T, Zhang D, Li Z BMC Cancer. 2024; 24(1):1064.

PMID: 39198775 PMC: 11351591. DOI: 10.1186/s12885-024-12843-0.


Diversity of Intercellular Communication Modes: A Cancer Biology Perspective.

Ebrahim T, Ebrahim A, Kandouz M Cells. 2024; 13(6.

PMID: 38534339 PMC: 10969453. DOI: 10.3390/cells13060495.


EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets.

Stergiou I, Papadakos S, Karyda A, Tsitsilonis O, Dimopoulos M, Theocharis S Cancers (Basel). 2023; 15(15).

PMID: 37568780 PMC: 10417178. DOI: 10.3390/cancers15153963.


Unraveling the Potential of EphA4: A Breakthrough Target and Beacon of Hope for Neurological Diseases.

Verma M, Chopra M, Kumar H Cell Mol Neurobiol. 2023; 43(7):3375-3391.

PMID: 37477786 PMC: 11409998. DOI: 10.1007/s10571-023-01390-0.